John Colvard
About John Colvard
John Colvard is a Clinical Account Manager with extensive experience in gaining formulary approvals at major healthcare institutions in the Southeast. He has played significant roles in the launch of ultra-orphan drugs and has a strong background in sales and account management within the pharmaceutical industry.
Work at Travere Therapeutics
John Colvard has been employed at Travere Therapeutics since 2014, serving as a Clinical Account Manager in Atlanta, GA. In this role, he is responsible for promoting the company's products to a range of healthcare professionals, including academic institutions, geneticists, pediatric hepatologists, gastroenterologists, and urologists. His focus extends across Georgia, Alabama, and Florida, where he engages with key regional, community, and pediatric hospitals. His expertise in gaining formulary approvals has been instrumental in advancing the company's initiatives within these healthcare settings.
Education and Expertise
John Colvard earned a Bachelor’s degree in Business Administration from The University of Georgia, where he studied from 1982 to 1986. His educational background has equipped him with the skills necessary to navigate the complexities of the pharmaceutical industry. He possesses specialized expertise in securing formulary approvals at major academic and teaching institutions, as well as community hospitals, particularly in the Southeast region of the United States.
Background
Prior to his current role, John Colvard held various positions in the pharmaceutical industry. He worked as a Regional Account Manager at Anesiva, Inc. for 10 months in 2008 and as a Senior Sales Executive at PCG Molecular, Inc. from 2012 to 2014. His earlier experience includes serving as a Regional Business Manager for Chiron Corporation from 1997 to 2005, where he managed sales in the pulmonology sector. This diverse background has contributed to his comprehensive understanding of clinical account management.
Achievements
Throughout his career, John Colvard has played a significant role in the launch of important pharmaceutical products. Notably, he was involved in the launch of Thiola, an ultra-orphan drug for the treatment of cystinuria, a rare genetic kidney disease. He also successfully launched Cholbam, the first FDA-approved treatment for Bile Acid Synthesis Disorders due to single enzyme defects. His contributions have helped to improve treatment options for patients with rare diseases.
Sales Leadership Experience
John Colvard has demonstrated strong leadership in sales throughout his career. He has led regional sales teams to consistently exceed company objectives, achieving top rankings in sales goal accomplishment. His ability to drive sales performance has been evident in his roles across various companies, where he has focused on building relationships with healthcare providers and promoting innovative treatments.